Viking Therapeutics, Inc.

0VQA•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£33.66

-4.65%

End of day

Market Cap

$2.44B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-4.98	6.16	0.60	0.35	0.71	—	0.94
Calmar	—	20.01	1.05	0.41	0.91	—	3.52
Sharpe	-4.98	3.84	0.38	0.21	0.52	—	0.49
Omega	0.12	1.65	1.12	1.09	1.18	—	1.14
Martin	-58.46	66.16	2.53	0.83	1.93	—	6.29
Ulcer	0.49	3.15	9.13	16.81	20.62	—	13.64

Also Listed On

VKTX.US

United States · USD

$3.76B

Viking Therapeutics, Inc. (0VQA) Price Performance

Viking Therapeutics, Inc. (0VQA) trades on London Stock Exchange in GBP. The stock currently trades at GBP33.66, down 4.65% from the previous close.

Over the past year, 0VQA has traded between a low of GBP23.60 and a high of GBP42.06. The stock has gained 28.5% over this period. It is currently 20.0% below its 52-week high.

Viking Therapeutics, Inc. has a market capitalization of $2.44B.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): -0.73
Book Value: 5.57

Technical Indicators

52 Week High: £59.06
52 Week Low: £23.09
50 Day MA: £32.40
200 Day MA: £32.49
Beta: 0.82

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: 6.09
Enterprise Value: $3.24B